Literature DB >> 11736717

Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study.

H H Xia1, B C Wong, K W Wong, S Y Wong, W M Wong, K C Lai, W H Hu, C K Chan, S K Lam.   

Abstract

BACKGROUND: The proportion of duodenal ulcers not associated with Helicobacter pylori infection or the use of non-steroidal anti-inflammatory drugs (NSAIDs) is increasing. AIM: To identify the clinical and endoscopic characteristics of non-H. pylori, non-NSAID duodenal ulcers.
METHODS: Clinical and endoscopic data and H. pylori status were prospectively collected from consecutive patients who underwent upper endoscopy from 1997 to 1999. Patients with duodenal ulcers were identified, and those with non-H. pylori, non-NSAID duodenal ulcers were analysed further.
RESULTS: A total of 11 717 upper endoscopies were performed in 8344 patients. Of these, 1153 (14%) had duodenal ulcers. Of 599 patients with active ulcers and known H. pylori status, 104 (17%) had ulcers not associated with H. pylori or the use of NSAIDs, 393 (66%) had ulcers associated with H. pylori alone, 51 (8.5%) had ulcers associated with the use of NSAIDs alone and 51 (8.5%) had ulcers associated with both. Multivariate logistic regression analysis revealed that the presence of concomitant diseases (odds ratio=15.0; 95% confidence interval, 8.64-25.9; P < 0.001) and the absence of epigastric pain/discomfort (odds ratio=0.52; 95% confidence interval, 0.29-0.91; P=0.022) were independent predictors for non-H. pylori, non-NSAID duodenal ulcers.
CONCLUSIONS: Non-H. pylori, non-NSAID duodenal ulcers exhibit certain distinct clinical and endoscopic characteristics. The presence of concomitant diseases is an important predictive factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11736717     DOI: 10.1046/j.1365-2036.2001.01115.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

Review 1.  Precise role of H pylori in duodenal ulceration.

Authors:  Michael Hobsley; Frank I Tovey; John Holton
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

2.  Unidentified intralesional and intracellular coccoid microorganism discovered in the young man with a diffuse erosive gastroduodenitis and multiple superficial ulcerations.

Authors:  Takayuki Okada; Graham Adkins
Journal:  BMJ Case Rep       Date:  2014-02-04

3.  Herpes simplex virus type 1 in peptic ulcer disease: an inverse association with Helicobacter pylori.

Authors:  Klisthenis Tsamakidis; Efstathia Panotopoulou; Dimitrios Dimitroulopoulos; Dimitrios Xinopoulos; Maria Christodoulou; Alexandra Papadokostopoulou; Ioannis Karagiannis; Elias Kouroumalis; Emmanuel Paraskevas
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

4.  Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers.

Authors:  Yaron Niv; Doron Boltin; Marisa Halpern; Miriam Cohen; Zohar Levi; Alex Vilkin; Sara Morgenstern; Vahig Manugian; Erica St Lawrence; Pascal Gagneux; Sukhwinder Kaur; Poonam Sharma; Surinder K Batra; Samuel B Ho
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 5.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

6.  Gastric mucin expression in Helicobacter pylori-related, nonsteroidal anti-inflammatory drug-related and idiopathic ulcers.

Authors:  Doron Boltin; Marisa Halpern; Zohar Levi; Alex Vilkin; Sara Morgenstern; Samuel B Ho; Yaron Niv
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

7.  Risk factors involved in patients with bleeding peptic ulcers: a case-control study.

Authors:  Sesha S Uppalapati; James D Boylan; Jill Stoltzfus
Journal:  Dig Dis Sci       Date:  2008-07-22       Impact factor: 3.199

8.  Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study.

Authors:  Hyun Joo Jang; Min Ho Choi; Woon Geon Shin; Kyung Ho Kim; Yong Woo Chung; Kyoung Oh Kim; Cheol Hee Park; Il Hyun Baek; Kwang Ho Baik; Sea Hyub Kae; Hak Yang Kim
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role?

Authors:  Harry Hua-Xinag Xia; Shiu Kum Lam; Wai Man Wong; Wayne Hsing-Cheng Hu; Kam Chuen Lai; Sau Hing Wong; Suet Yi Leung; Siu Tsan Yuen; Nicholas A Wright; Benjamin Chun-Yu Wong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

10.  Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers.

Authors:  Yaron Niv; Doron Boltin; Marisa Halpern; Miriam Cohen; Zohar Levi; Alex Vilkin; Sara Morgenstern; Vahig Manugian; Erica St Lawrence; Pascal Gagneux; Surinder K Batra; Samuel B Ho
Journal:  Dig Dis Sci       Date:  2012-05-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.